Outset Medical, Inc.

NASDAQ:OM

Medical - Devices

Healthcare
$3.04 +18.16%

+$0.73 today

Market cap
$57.31M
Beta
1.94
P/E (TTM)
-1.2
EPS (TTM)
-$4.07
52W Low $3.00High $21.36

Volume 0.05M

Average 0.16M

OM Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Outset Medical, Inc.NASDAQ: OM

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) growth accelerates

Q1 FY2026 weighted avg shares (diluted) of 18.37M shares rose 430.5% year over year, ahead of the +423.3% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 3.1% from the prior quarter. Over 3 fiscal years it compounded at +68.0% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +430.5% holds above the trailing-twelve-month pace of +423.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
18.37M+3.1% QoQ
Last fiscal yearDec 2025
15.21M+339.2% YoY
LTMMar 2026
17.93M+423.3% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+430.5%——
1 year+339.2%——
3-year CAGR+68.0%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
15.21M USD
Year-over-year change
+339.2%
4-year CAGR
+49.6%

Weighted Avg Shares (Diluted) vs competitors

How OM compares with its peers on the latest reported figures

  • OM's LTM Mar 2026 weighted avg shares (diluted) of 17.93M shares is the 9th highest of the 10 companies compared; the peer median is 40.56M shares.
  • Its year-over-year change of +423.3% is the 2nd highest of 10, against a peer median of +12.1%.
  • Over three fiscal years its annual growth of +68.0% compares with a peer median of +8.9%.
OM Competitors Peer median
Weighted Avg Shares (Diluted) for OM and competitors
Company Period LTM YoY 3-year CAGR
TNYATenaya Therapeutics, Inc.LTM Mar 2026158.02M +71.7%+50.6%
NNOXNano-X Imaging Ltd.LTM Dec 202564.81M +10.5%+7.4%
CATXPerspective Therapeutics, Inc.LTM Mar 202654.95M -21.6%+10.4%
QTRXQuanterix CorporationLTM Mar 202644.68M +16.0%+4.9%
VMDViemed Healthcare, Inc.LTM Mar 202640.56M -1.4%+0.8%
INGNInogen, Inc.LTM Mar 202626.97M +12.1%+5.9%
HSDTSolana CompanyLTM Mar 202625.93M +788.1%+244.4%
SIShoulder Innovations, Inc.LTM Mar 202620.52M +3.0%—
OMOutset Medical, Inc.LTM Mar 202617.93M +423.3%+68.0%
SNWVSANUWAVE Health, Inc.LTM Mar 20269M +86.9%+83.7%
Peer median (excluding OM) 40.56M+12.1%+8.9%

Competitors are the stored peer set for OM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue102.6M115.38M130.38M113.69M119.48M
Cost of Revenue94.99M97.54M101.38M75.13M72.72M
Gross Profit7.61M17.83M29M38.56M46.75M
Gross Margin7.4%15.5%22.2%33.9%39.1%
Research & Development36.74M48.86M57.31M38.4M21.24M
Selling, General & Admin101.39M130M141.46M113.54M92.23M
Operating Expenses138.13M178.85M198.77M151.94M113.46M
Depreciation & Amortization5.16M6.28M5.81M5.73M4.34M
EBITDA(124.86M)(152.81M)(153.79M)(97.89M)(62.37M)
EBITDA Margin-121.7%-132.4%-118.0%-86.1%-52.2%
Operating Income(130.52M)(161.02M)(169.77M)(113.38M)(66.71M)
Operating Margin-127.2%-139.6%-130.2%-99.7%-55.8%
Interest Income498K3.29M10.17M9.76M7.41M
Interest Expense1.72M3.57M12.68M23.87M13.95M
Other Income / Expenses(1.22M)(1.64M)(2.5M)(14.11M)(14.22M)
Income Before Tax(131.74M)(162.66M)(172.27M)(127.49M)(80.94M)
Pre-Tax Margin-128.4%-141.0%-132.1%-112.1%-67.7%
Income Tax Expense199K295K523K491K718K
Net Income(131.94M)(162.96M)(172.8M)(127.98M)(81.65M)
Net Margin-128.6%-141.2%-132.5%-112.6%-68.3%
EPS (Basic)(43.41)(50.75)(52.27)(36.95)(5.37)
EPS (Diluted)(43.41)(50.75)(52.27)(36.95)(5.37)
Weighted Avg Shares3.04M3.21M3.31M3.46M15.21M
Weighted Avg Shares (Diluted)3.04M3.21M3.31M3.46M15.21M

Outset Medical, Inc.

NASDAQ:OM

Intrinsic Alpha fair value

Locked

Current Price

$3.04

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.